#

Biotechnology

: 158
Victorias Secret revenue for the first quarter of its fiscal 2026 came in 15% higher versus a year earlier and beat analysts expectations / Photo: Azulblue / Shutterstock.com
Small Caps·
Small caps last week: Victoria's Secret rally, Virgin Galactic selloff, GoPro warning
This years FIFA World Cup will be held in three countries - the United States, Mexico and Canada. Pictured are FIFA President Gianni Infantino, U.S. President Donald Trump, Mexican President Claudia Sheinbaum and Canadian Prime Minister Mark Carney. Photo: The White House
Review·
There will be a virus-hunting technology race at the World Cup. Who's in the race?
The most important point for investors to remember is that promise does not equal safety in biotech, notes Igor Klyushnev / Photo: Shutterstock.com
Small Caps·
Three biotech stories to invest in now: LSD therapy, challenge to leader, first sales
Abivax shares collapsed nearly 30% after new data on its drug was released / Photo: abivax.com
News·
Shares of biotech Abivax plummet 30% after reports of cancer in trial participants
Redwire shares have more than tripled year to date, now trading 40% above the consensus target price from Wall Street analysts / Photo: X / Redwire
Small Caps·
Small caps last week: Space stocks rally, 'GLP-1 moment for hair loss', LUNR snubbed
Roughly 80 million Americans live with hair loss, while the U.S. Food and Drug Administration last approved a new hair loss treatment 30 years ago, BTIG notes / Photo: Shutterstock.com
Small Caps·
BTIG initiates on Absci as leader of 'GLP-1 moment for hair loss'; stock jumps 18%
As Elon Musk readies SpaceX for a highly anticipated initial public offering, Wall Street is racing to find the next big winner in space exploration, Bloomberg writes / Photo: SpaceX
Small Caps·
Small caps last week: Ebola vaccine, SpaceX IPO beneficiaries, Russell rebalancing
The WHO has declared the outbreak an emergency / Photo: GeoVax
Small Caps·
Ebola outbreak sends shares of vaccine maker GeoVax skyrocketing
GMR specializes in emergency medical care / Photo: GMR
News·
GMR IPO: emergency ambulance service provider goes public
Founded in 2021, Odyssey is developing therapies to treat patients with autoimmune diseases like ulcerative colitis, Crohn’s disease, and lupus / Photo: Odyssey Therapeutics
Small Caps·
Odyssey IPO: Immune system biotech debuts on the Nasdaq
Once the deal closes, Esperion will be delisted from the Nasdaq, which removes a once-public cardiometabolic pure-play from the small-cap biotech universe, notes Noble / Photo: Instagram / Esperioninc
Small Caps·
Small-cap biotech Esperion to be taken private by ARCHIMED; shares jump more than 50%
Small caps last week: Peloton on Spotify, biotech M&A, small-cap ETF leaders
Small Caps·
Small caps last week: Peloton on Spotify, biotech M&A, small-cap ETF leaders
Load more